ArticleCommunications medicine2025

Progression-free survival for unresectable non-metastatic locally advanced pancreatic cancer after surgical microwave ablation plus durvalumab and tremelimumab: phase-2 non-randomized prospective clinical trial.

Halit Topal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.